References of "Chevalier, T"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailAssessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)
Bruyère, Olivier ULg; Rizzoli, René; Coxam, V. et al

in Osteoporosis International (2012), 23

Health claims for food products in Europe are permitted if the nutrient has been shown to have a beneficial nutritional or physiological effect. This paper defines health claims related to bone health and ... [more ▼]

Health claims for food products in Europe are permitted if the nutrient has been shown to have a beneficial nutritional or physiological effect. This paper defines health claims related to bone health and provides guidelines for the design and the methodology of clinical studies to support claims. [less ▲]

Detailed reference viewed: 56 (28 ULg)
Full Text
Peer Reviewed
See detailMéthodologie de l'enquête MISSION (Ménopause, risque de cancer du sein, morbidité et prévalence)
Chevalier, T.; Daures, J. P.; Micheletti, M. C. et al

in Journal de Gynécologie, Obstétrique et Biologie de la Reproduction (2005), 34(7-C1), 658-665

Objective. The ambition of this article is to detail and to explain the methodology of the study named MISSION (Menopause: breast cancer risk, morbidity and prevalence). The aims of MISSION are to ... [more ▼]

Objective. The ambition of this article is to detail and to explain the methodology of the study named MISSION (Menopause: breast cancer risk, morbidity and prevalence). The aims of MISSION are to determine the prevalence of breast cancer and global morbidity in France among menopausal women treated or not with hormone replacement therapy (HRT) and followed by a gynecologist. Material and method. 6600 menopausal women [3300 with HRT — ie for estrogen: only estradiol via oral or transdermal administration; for progestogen: natural progesterone or assimiled or one pregnane derived (excluding medroxyprogesterone acetate) or non-pregnane derived — and 3300 without HRT] will be enrolled in France between January 5 2004 and February 28 2005 by 825 gynecologists, members or not of the National Federation of Medical Gynecologists (FNCGM). This study design is a historico-prospective with case randomization. MISSION is conducted by a Theramex-Merck Laboratories initiative in collaboration with a WHO (World Health Organization) Collaborating Center for Public Health Aspects of Rheumatic Diseases and a multidisciplinary expert group. Conclusion. First results of this study will contribute to better knowledge of women health. [less ▲]

Detailed reference viewed: 94 (9 ULg)
Full Text
Peer Reviewed
See detailEffects of two 1-year calcium and vitamin D3 treatments on bone remodeling markers and femoral bone density in elderly women
DEROISY, Rita ULg; Collette, Julien ULg; Chevalier, T et al

in Current Therapeutic Research (1998), 59(12), 850-862

Detailed reference viewed: 17 (1 ULg)